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Abstract
Background: Abnormal vaginal bleeding (AVB) in women of reproductive age is a common reason
for consulting a general practitioner. Nevertheless, how general practitioners (GPs) choose to
initially manage AVB is largely unknown, as is the prevalence of underlying pathology of AVB in
primary care.
Methods: To investigate the initial diagnostic procedures and treatment for AVB used in general
practice, we performed a descriptive study based on computerised medical records. New
consultations for AVB in 2000 and 2001 were selected. Patient characteristics, diagnostic
procedures and treatment were analysed.
Results: In total, 270 new consultations were included. The majority of patients (75%) consulted
the GP for AVB only once. GPs performed diagnostic procedures in 54% of all consultations.
Overall, additional diagnostic procedures revealed abnormalities in 11% of women. However, the
diagnostic procedures implemented by the GPs varied widely per bleeding type and contraceptive
use. Anaemia was found in 36% of 45 women tested. Uterine fibroids were found in 41% of 27
women examined by ultrasound. Medication was prescribed in 34% of all consultations. A
gynaecological referral was registered in 4% of all contacts.
Conclusion:  Initially, GPs tend to follow a policy of expectant management in women of
reproductive age with AVB. However, when additional diagnostic procedures were performed,
anaemia and uterine fibroids were found in a considerable number of women.
Background
Abnormal vaginal bleeding (AVB) is a frequent reason for
women of reproductive age to consult a general practi-
tioner (GP). AVB can be categorised as excessive men-
strual bleeding, irregular bleeding and intermenstrual
including postcoital bleeding [1]. A population study car-
ried out in Dutch general practices revealed an incidence
of menorrhagia of 8 per 1000 women aged 25–44 years,
per year, while in irregular bleeding, including intermen-
strual and postcoital bleeding, the incidence is 17 per
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1000 women aged 25–44 years, per year [2]. However, lit-
tle is known about which diagnostic procedures are cho-
sen by GPs to differentiate between causes of AVB and to
implement its therapeutic management in general prac-
tice [3-5].
Since the late nineties, several national practice guidelines
for the management of abnormal vaginal bleeding in gen-
eral practice have been published [1,6,7]. In the Nether-
lands, the guideline 'Vaginal bleeding' from the Dutch
College of General Practitioners, was published in 1992
and revised in 2001 [1]. Data on causes of AVB in primary
care are scarce. Consequently, these guidelines were
mostly based on data acquired in secondary care and gave
no specific advice on diagnostic methods. To fill this gap,
we studied the use and outcome of initial diagnostic pro-
cedures and the therapeutic management by GPs of
women of reproductive age with AVB.
Methods
This study was carried out in an urban primary healthcare
centre which provides care to 11,500 patients, including
3,435 women at risk (20–55 years). The age and sex distri-
bution of the practice population is largely comparable
with the general Dutch population [8]. The centre submits
data to the continuous morbidity registration network at
the Department of General Practice at the Academic Med-
ical Center, University of Amsterdam.
GPs working at the healthcare centre record all consulta-
tions on a computerised database. The medical problems
presented during consultations are recorded using Inter-
national Classification of Primary Care (ICPC) codes [9]
and associated free text is used to report reason for consul-
tation, diagnostic procedures performed, medication pre-
scribed and referrals to secondary care. This information is
then stored in an anonymous database which is available
for analysis. From this database, we selected all recorded
consultations concerning abnormal vaginal bleeding in
women aged between 20 to 55 years between January
2000 and January 2002 using ICPC codes and truncated
text words. The ICPC codes used were: menorrhagia
(X06), irregular bleeding (X07), intermenstrual bleeding
(X08), menopause (X11), bleeding after sexual inter-
course (X13), endometritis/pelvic inflammatory disease
(X74), malignancy of female reproductive organs (X77),
uterine fibroids (X78), and injuries of female reproductive
organs (X82). After a pilot test using the same database
but a different time period, successful truncated text
words were found to be: %blood loss%, %spotting%,
%flow%, %contact bleeding%, %menstr%, %cycle%,
%dysbalance%, %gyn%, %ovary%, %fibroid%,
%menor%, %metror%. All recorded consultations in
which the free text contained the truncated text words
were also selected.
The text of all consultations identified by ICPC codes and
text words, was read by two authors (CJHdV and CLAGV)
and scored independently on the following issues: type of
bleeding pattern, use of hormonal contraceptives, diag-
nostic procedures performed by GPs, any prescribed med-
ication, and referrals to a gynaecologist. Any disagreement
was resolved by consensus. Type of bleeding pattern was
categorised according to the Dutch guideline on vaginal
bleeding. The following three patterns were defined. Irreg-
ular bleeding i.e. non-cyclical bleeding, as a result of
which menstrual bleeding can no longer be recognised.
Excessive bleeding i.e. cyclical bleeding excessive in either
volume or duration, and intermenstrual bleeding i.e.
bleeding in the interval between recognisable periods [1].
The fourth category was a combination of bleeding pat-
terns, irregular and intermenstrual bleeding or excessive
and intermenstrual bleeding. No use of hormonal contra-
ceptives, or the use of a copper intrauterine device were
clustered and described as no hormonal contraceptive
use. The use of oral contraceptive pills, depot medroxy-
progesterone acetate or levonorgestrel-releasing intrauter-
ine system was clustered and described as hormonal
contraceptive use.
To assess initial management we selected only new con-
sultations. A new consultation was defined as a consulta-
tion-free period of three months for AVB. As a
consequence, consultations for AVB from January to April
2000 were not included, as it was not known whether
there had been a consultation-free period of three months
for AVB. The same holds for consultations without a three
months follow-up, i.e. women who first presented
between October 2001 and January 2002. Women who
went for their first consultation in these months were
excluded.
The number of consultations for the same type of bleed-
ing was registered. A consultation after three months for a
different type of bleeding was considered to be a new epi-
sode. These recurrent episodes were not analysed. Preg-
nant and postmenopausal women were excluded, as were
those patients who had started hormonal contraception
three months before consultation. The incidence of AVB is
represented as the number of new episodes per 1000
women per year. The numerator concerns new episodes of
AVB, the denominator concerns the population size of
women at risk.
Management was described in terms of the number and
proportion of patients undergoing physical examination
(bimanual examination and speculum examination) or
laboratory testing (cervical smear, Chlamydia test, preg-
nancy test, haemoglobin test), additional diagnostic pro-
cedures (ultrasonography), prescribed medication
(hormonal, non-steroidal anti-inflammatory drugs, ironBMC Women's Health 2008, 8:7 http://www.biomedcentral.com/1472-6874/8/7
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suppletion, other medical treatment) or referral to a
gynaecologist. The categories of investigations were not
mutually exclusive (i.e. a GP may have performed several
diagnostic tests). Data were analysed in SPPS version 14.0.
Results
General characteristics
A total of 270 consultations by women with AVB were
recorded and selected from the database. The incidence of
new cases of AVB was 52 per 1,000 women per year. Most
women (75%) consulted the GP only once for AVB. The
median age of the women was 41 years (interquartile
range 36–46). Overall reasons for consultation were
mainly an irregular bleeding pattern (40%) and excessive
bleeding (36%) (see Table 1). The majority of the women
(70%) did not use hormonal contraceptives (Table 1). In
this group excessive bleeding (43%) and irregular bleed-
ing (42%) were almost equally often recorded as reason
for consultation (see Table 2). Intermenstrual bleeding
was the most frequently seen symptom (41%) in women
using hormonal contraceptives (see Table 2). In three con-
sultations, a combination of bleeding pattern was
recorded (results not shown).
Diagnostic procedures
Overall, GPs used only history taking to assess bleeding
symptoms in 46% of all consultations. However, the
methods of assessment of AVB varied widely per type of
bleeding and hormonal contraceptive use. In consulta-
tions concerning intermenstrual bleeding without hor-
monal contraceptive use, GPs used only the history as a
diagnostic tool in 25% of consultations, in contrast to
56% in consultations concerning irregular bleeding with-
out hormonal contraceptive use.
Physical examination (bimanual and/or speculum exam-
ination) was performed in 37% of all consultations, most
frequently in consultations for intermenstrual bleeding
without contraceptive use (21/28, 75%) (see Table 2). In
cases of intermenstrual bleeding cervical smears (20/33)
and testing for Chlamydia (18/26) were the most fre-
quently carried out tests, whereas in consultations for
excessive bleeding haemoglobin tests were most often
performed (26/45). Ultrasound examination was used in
27 (10%) of all consultations, mainly in those women
with excessive bleeding (12/27).
Diagnostic test results
Overall, additional procedures revealed abnormalities in
11% of women. Findings on bimanual and speculum
examination as noted by GPs were too diverse to interpret
retrospectively as being either normal or abnormal. Of all
33 cervical smears performed, three were Pap stage 2 (bor-
derline smear) [10]. One of the 26 Chlamydia tests was
positive. A low haemoglobin level (< 7.5 mml/L) was
noted in 16 of 45 tested women (36%), most frequently
(14/26, 54%) in women with symptoms of excessive
bleeding. None of the pregnancy tests were positive. Of
the 27 ultrasound examinations, uterine fibroids were
reported in 11 cases (41%). One was described as indis-
tinctive, 13 (48%) were described as normal, while two
results were missing (see Table 3). Uterine fibroids were
found on 7/10 (70%) ultrasound examinations on
women with excessive bleeding who were not taking hor-
monal contraceptives (results not shown).
Initial management
Initially, in slightly less than two-thirds (62%) of all
women, the GPs did not prescribe medication. Depending
on bleeding pattern and hormonal contraceptive use, this
percentage decreased to 43% (34/80) in excessive bleed-
ing without hormonal contraceptive use and rose to 93%
(26/28) in intermenstrual bleeding without hormonal
contraceptive use. In about a quarter (65/270) of the con-
sultations, hormonal treatment (hormonal contraceptive
pill or progesterone) was prescribed. In 35% (28/80) of
the consultations concerning excessive bleeding without
hormonal contraception, hormonal treatment was pre-
scribed. NSAIDs were prescribed in 5% of the consulta-
tions. Excessive bleeding was the main indication. In four
percent of all cases, GPs referred the women to a gynaecol-
ogist (Table 4). Reasons for referral were findings on phys-
ical examination and blood testing (2/11), a history of
gynaecological abnormalities (2/11), use of co-medica-
tion (1/11), specific diagnostic investigation or treatment
not assessable by the GP (5/11) and on patient's request
(1/11).
Discussion
In this study we found that GPs tend to initially follow a
policy of expectative management in women of reproduc-
tive age who are seen for abnormal vaginal bleeding. The
Table 1: General characteristics
General characteristics n (%)*
Number of patients 270
Number of patients with one consultation only 203 (75)
Median age, yrs (interquartile range) 41 (36–46)
Type of bleeding
Irregular 107 (40)
Excessive 98 (36)
Intermenstrual 62 (23)
Combination 3 (1)
HC use
No ** 188 (70)
Yes *** 82 (30)
Abbreviations: HC use: hormonal contraceptive use.* Numbers are n 
(%).** Included use of copper iud n = 14. *** Hormonal contraceptive 
pill: n = 65, depot medroxyprogesterone acetate or levonorgesterel-
releasing intrauterine system: n = 17.BMC Women's Health 2008, 8:7 http://www.biomedcentral.com/1472-6874/8/7
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majority of the women (75%) consulted the GP only
once. GPs tend to base their medical management on his-
tory taking only, and they were restrictive in their prescrip-
tion of medication. However, GP's use of physical
examination and additional diagnostic tests varied widely
per bleeding type and pre-existing contraceptive use. If
GPs performed additional diagnostic procedures, anae-
mia and uterine fibroids were the most frequently diag-
nosed conditions.
In this study, the symptoms and management of AVB
were studied in a general practice setting. Because we used
both truncated text words and ICPC codes, our study pop-
ulation was most likely complete and thus to have pro-
vided reliable information. The quality assurance
programme in the network concentrated on detailed reg-
istration and data quality. Half-yearly meetings were
organised, where feedback based on aggregated data were
presented to practices, and differences were discussed.
Since data can only be checked when registered in the
medical records, it cannot be excluded that physical exam-
inations were actually performed more often than was
reported. Missing haemoglobin results and ultrasound
findings could be explained by different pathways of per-
forming these tests (at the healthcare centre or in a labo-
ratory), or of reporting test results. The missing results are
considered random and not related to the origin of AVB or
outcome. The data were not collected recently, but since
studies on symptoms of abnormal vaginal bleeding and
its underlying pathology in primary care are still lacking,
our data provide good insight in the management of AVB
[11,12].
With two exceptions, the Dutch guidelines recommend a
bimanual and speculum examination in all women,
regardless of bleeding pattern. The two groups in whom it
is not considered necessary to perform a physical exami-
nation are; virgins during the five years after the menarche
and women with intermenstrual bleeding, who use hor-
monal contraceptives, do not have post-coital bleeding or
are not at risk of sexually transmitted diseases [1]. The
recently published NICE guideline 'Heavy Menstrual
Bleeding' does not recommend a bimanual examination
and/or speculum examination be initially carried out in
women with heavy menstrual bleeding unless there are
'red flag' symptoms (postcoital bleeding, intermenstrual
bleeding, pelvic pain or pressure symptoms) [13]. In our
study bimanual and/or speculum examination was ini-
tially performed in 29% of women with excessive bleed-
ing who did not use hormonal contraceptives, so the
NICE guideline may reflect current practice more closely
than the Dutch guideline [1,13]. However, we found that
GPs seldom registered their reasons for ignoring the
guideline's recommendations.
Variations in management found in the literature can be
explained by different definitions of the observation
period for AVB. For example in a study that analysed a
general practice register, gynaecological examination was
observed to be performed more frequently (42%) in
women with excessive bleeding. The observation period
in this study was substantially longer (four years) and epi-
sode-based [3].
Most of the investigations performed by the GPs in our
study resulted in normal findings, especially in women
with intermenstrual bleeding. In a 2006 review of postco-
ital bleeding and the risk of cervical cancer in primary
Table 2: Initial investigations by GPs in women with abnormal vaginal bleeding
All types of bleeding Irreg. HC- Irreg. HC+ Excess. HC- Excess. HC+ Interm. HC- Interm. HC+
n = 270* n = 78 n = 29 n = 80 n = 18 N = 28 n = 34
History only 125 (46) 44 (56) 10 (35) 41(51) 8 (44) 7 (25) 14 (41)
Any investigation 145 (54) 34 (44) 19 (65) 39 (49) 10 (56) 21 (75) 20 (59)
Gyn. exam. 101 (37) 21 (27) 14 (48) 23 (29) 4 (22) 21 (75) 16 (47)
Cervical smear 33 (12) 2 (3) 6 (21) 4 (5) 0 10 (36) 10 (29)
Chlamydia test 26 (10) 3 (4) 3 (10) 1 (1) 0 11 (39) 7 (21)
Haemoglobin test 45 (17) 14(18) 3 (10) 21 (26) 5 (28) 1 (4) 1(3)
Pregnancy test 8 (3) 3 (4) 1 (3) 0 1(6) 3 (11) 0
Ultrasound 27 (10) 4 (5) 5 (17) 10 (13) 2 (11) 4 (14) 2 (6)
Abbreviations: Irreg.: irregular bleeding. Excess.: excessive bleeding. Interm.: intermenstrual bleeding. HC-: no hormonal contraceptive (included 
use of copper intrauterine device). HC+: hormonal contraceptive (hormonal contraception pill, depot medroxyprogesterone acetate of 
levonorgesterel-releasing intrauterine system). Gyn.exam: gynaecological examination (bimanual or speculum examination).
*Numbers are n (%).
Table 3: Abnormal findings in investigations
Abnormal findings n (n tests) %
Pap stage 2 3 (33) 9
Positive Chlamydia-test 1 (26) 4
Haemoglobin level < 7.5 mm/L 16 (45)* 36
Positive pregnancy test 0 (8) 0
Uterine fibroids on ultrasound 11 (27)** 41
* Three test results missing. ** Two test results missing.BMC Women's Health 2008, 8:7 http://www.biomedcentral.com/1472-6874/8/7
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care, Shapley states that symptoms are common and the
presence of cancer is a rarity [11]. However, in our study
we found a low haemoglobin level in 36%, and, on ultra-
sound, uterine fibroids in 41% of the patients examined.
There is still little known about the prevalence of these
abnormalities in primary care [1,12,13]. Other studies
estimate the prevalence of uterine fibroids in patients
referred with abnormal uterine bleeding to be between
30%–60% [14-16]. The causal relation between AVB and
uterine fibroids is still under discussion. We raise the
question of whether uterine fibroids are being under-diag-
nosed by GPs in women with symptoms of abnormal vag-
inal bleeding, because of the limited use of
ultrasonography [17,18]. To answer this question the use
of ultrasonography should be studied in a larger primary
care population.
In the Netherlands hormonal treatment (oral contracep-
tive pill or progestagens) is the preferred medical treat-
ment in all types of AVB with no underlying cause [1]. Our
study found that hormonal treatment was mainly pre-
scribed in cases of excessive bleeding (35% in consulta-
tions without hormonal contraceptive use). However, in
slightly less than two-thirds of the consultations GPs did
not prescribe any medication. This was higher than in an
episode-based study in which 23% of the women received
no medication [3]. We found that most women with AVB
consulted their GP only once. It is questionable whether
expectant policy with regard to medication prescription is
wise, as studies have established that interference in daily
life by heavy periods is an important factor for consulting
a GP, and that women prefer treatment which improves
their ability to manage menstruation [19,20]. However, as
patients rarely returned to their GP with the same prob-
lem, the limited and mainly hormonal treatment options
available in primary care may not be a preferable alterna-
tive, especially for patients aged 40 and older. The expla-
nation and reassurance from the GP is presumably
enough for the patient to accept a policy of expectant
management. We think it unlikely that patients went else-
where as in the Dutch health system, patients are regis-
tered with only one general practice and it is not possible
to consult other GPs.
Appropriate medical treatment may prevent referral to a
gynaecologist. Our study demonstrated that in four per-
cent of all consultations women were initially referred to
a gynaecologist. In another study, the mean annual refer-
ral rate to gynaecology for menorrhagia was nine per 1000
women, aged 30–49 years per year [3]. In our study it was
initially one per 1000 women per year in this subgroup.
Conclusion
In conclusion, this study shows that GPs appear to regard
AVB as a problem that initially only needs limited further
evaluation. However, depending on the type of AVB, there
are good reasons for implementing a more active policy.
Ultrasonography may be of use to allow GPs to establish
whether uterine abnormalities are actually responsible for
AVB.
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Table 4: Initial management by GPs in women with abnormal vaginal bleeding
All types of bleeding Irreg. HC- Irreg. HC+ Excess. HC- Excess. HC+ Interm. HC- Interm. HC+
n = 270* N = 78 n = 29 n = 80 n = 18 n = 28 n = 34
No medication 167 (62) 48 (62) 21 (72) 34 (43) 9 (50) 26 (93) 28 (82)
Medication 92 (34) 25 (32) 8 (28) 45 (56) 8 (44) 2 (7) 2 (6)
Hormonal treatment 65 (24) 22 (28) 6 (21) 28 (35) 5 (28) 1 (4) 1 (3)
NSAID 13 (5) 2 (3) 1 (3) 8 (10) 2 (11) 0 0
Iron-suppletion 8 (3) 0 1(3) 7 (9) 1 (6) 0 0
Other 6 (2) 1 (1) 1 (3) 2(3) 0 1 (4) 1
Referral to gyn. 11 (4) 5 (6) 0 1 (1) 1 (6) 0 4 (12)
Abbreviations: Irreg.: irregular bleeding. Excess.: excessive bleeding. Interm.: intermenstrual bleeding. HC-: no hormonal contraceptive (included 
use of copper intrauterine device). HC+: hormonal contraceptive (hormonal contraception pill, depot medroxyprogesterone acetate of 
levonorgesterel-releasing intrauterine system). Referral to gyn: referral to gynaecologist.*Numbers are n (%).Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Women's Health 2008, 8:7 http://www.biomedcentral.com/1472-6874/8/7
Page 6 of 6
(page number not for citation purposes)
References
1. Meijer LJ, Zwart S, Westerveld MC, Wemekamp H, F.S. B, Burgers JS:
NHG-standaard Vaginaal Bloedverlies (eerste herziening).
[Dutch college of General Practitioners. Revised guideline
Vaginal Bleeding.].  Huisarts en wetenschap 2001, 44:260-266.
2. Linden MW, Westert GP, Bakker DH, Schellevis FG: Tweede Nationale
Studie naar ziekten en verrichtingen in de huisartspraktijk.Klachten en aan-
doeningen in de bevolking en in de huisartspraktijk.[Health complaints and
diseases in the population and in general practice. Second Dutch National
Survey of General Practice]. Utrecht, The Netherlands, Nivel; 2004. 
3. Grant C, Gallier L, Fahey T, Pearson N, Sarangi J: Management of
menorrhagia in primary care-impact on referral and hyster-
ectomy: data from the Somerset Morbidity Project.  J Epide-
miol Community Health 2000, 54:709-713.
4. O'Flynn N, Britten N: Diagnosing menstrual disorders: a quali-
tative study of the approach of primary care professionals.  Br
J Gen Pract 2004, 54:353-358.
5. Vigod SN, Stewart DE: Management of abnormal uterine bleed-
ing by northern, rural and isolated primary care physicians:
PART I - How are we doing?  BMC Womens Health 2002, 2:10.
6. Royal College of Obstetricians and Gynaecologists: The initial manage-
ment of menorrhagia London, RCOG Press; 1998. 
7. An evidence-based guideline for the management of heavy
menstrual bleeding. Working Party for Guidelines for the
Management of Heavy Menstrual Bleeding.  N Z Med J 1999,
112:174-177.
8. (CBS) ONS: Office for National Statistics (CBS).  2008 [http://
StatLine.CBS.nl].
9. Lamberts H, M W: International Classification of Primary Care Oxford,
Oxford University Press; 1987. 
10. Rebolj M, van Ballegooijen M, Berkers LM, Habbema D: Monitoring
a national cancer prevention program: successful changes in
cervical cancer screening in the Netherlands.  Int J Cancer 2007,
120:806-812.
11. Shapley M, Jordan J, Croft PR: A systematic review of postcoital
bleeding and risk of cervical cancer.  Br J Gen Pract 2006,
56:453-460.
12. Samuel NC, Justin CT: Future research into abnormal uterine
bleeding.  Best Pract Res Clin Obstet Gynaecol 2007.
13. National Institute for Health and Clinical Excellence: Clinical Guideline
Heavy Menstrual Bleeding London, NICE; 2007. 
14. Emanuel MH, Verdel MJC, Stas H, Wamsteker K, Lammes FB: An
audit of true prevalence of intra-uterine pathology: The hys-
teroscopical findings controlled for patient selection in 1202
patients with abnormal uterine bleeding.  In Gynaecological
Endoscopy Volume 4. United Kingdom; 1995:237-241. 
15. Critchley HOD, Warner P, Lee A, Brechin A, Guise J, Graham B:
Evaluation of abnormal uterine bleeding comparison of
three outpatient procedures within cohorts defined by age
and menopausal status.  Health Technol Assess 2004, 8:1-157.
16. Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ: Sono-
hysterography in premenopausal women with and without
abnormal bleeding.  Obstet Gynecol 1999, 94:516-520.
17. Ryan GL, Syrop CH, Van Voorhis BJ: Role, epidemiology, and nat-
ural history of benign uterine mass lesions.  Clin Obstet Gynecol
2005, 48:312-324.
18. Dodson MG: Use of transvaginal ultrasound in diagnosing the
etiology of menometrorrhagia.  J Reprod Med 1994, 39:362-372.
19. O'Flynn N: Menstrual symptoms: the importance of social fac-
tors in women's experiences.  Br J Gen Pract 2006, 56:950-957.
20. Santer M, Wyke S, Warner P: What aspects of periods are most
bothersome for women reporting heavy menstrual bleed-
ing? Community survey and qualitative study.  BMC Women's
Health 2007, 7:8.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6874/8/7/prepub